Publicado Aug 23, 2010



PLUMX
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar
Descargas


José del Carmen Rejón-Orantes

Diana Placer Perdomo

Gabriel Roldán

##plugins.themes.bootstrap3.article.details##

Resumen

En el último año, el Laboratorio Experimental de Farmacobiología de la Facultad de Medicina de la Universidad Autónoma de Chiapas (UNACH), ha venido sistematizando pruebas no condicionadas para el estudio de la ansiedad en modelos animales. 

En este trabajo se efectúa una revisión bibliográfica que actualiza el conocimiento sobre las pruebas útiles en la evaluación de la ansiedad. Estas pruebas las utilizamos en los trabajos de investigación de extractos vegetales con base en hallazgos etnobotánicos de la medicina tradicional chiapaneca, los cuales se han desarrollado con modestos recursos financieros de la Facultad de Medicina de la Universidad y autofinanciamiento por parte de los investigadores, considerando la generación de conocimiento y la posibilidad de ampliar las expectativas terapéuticas con recursos naturales, como el insumo de mayor valor.


Además, es de interés para el equipo investigador vincular en este proceso a investigadores de otras universidades e instituciones de salud que estén estudiando compuestos extraídos de plantas y que sirvan como base en la obtención de fármacos no sintéticos para tratamiento de la ansiedad en el hombre.

Keywords

ansiedad, extractos, alcaloides, anxiety, extracts, alkaloids,

References
1. WHO (World Health Organization). Quality Control methods for medicinal plant materials. Geneva, Switzerland. 1998;vii.
2. Evans SR, Hofmann A. Plantas de los dioses. Segunda edición. Ljublana, Slovenia: Fondo de Cultura Económica; 2008;62-3.
3. Hasrat JA, Bruyne T, Backer JP, Vauquelin G, Vlietinck AJ. Isoquinoline
derivatives Isolated from the fruit of Annona muricata as 5-Htergic 5-HT1A receptor agonists in rats: Unexploited antidepressive (lead) products. J Pharm Pharmacol. 1997;49:1145-9.
4. Organización de médicos indígenas del Estado de Chiapas, A.C. (OMIECH). Las plantas medicinales utilizadas por los mayas de los altos de Chiapas. Primera edición. San Cristóbal de las Casas, Chiapas: Editorial Fray Bartolomé de las Casas, A.C. 2006;7.
5. Dhawan K, Kumar S, Sharma A. Antianxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol. 2001;8:165-70.
6. Kidman A. Neurochemical and cognitive aspects of anxiety disorders.
Prog Neurobiol. 1989;32:391-402.
7. Gorman JM, Hirschfeld RM, Ninan PT. New developments in the neurobiological basis of anxiety disorders. Psychopharmacol Bull. 2002;36:49-67.
8. Celis CT, Rincón J, Guerrero MF. Actividad farmacológica sobre el sistema nervioso central del extracto etanólico y de la fracción alcaloidal de Valeriana pavonii. Rev Col Cienc Quím Farm. 2007;36:11-22.
9. Amos S, Binda L, Chindo BA, Tseja A, Odutola AA, Wamebe C, et al.
Neuropharmacological effects of Hibiscus sabdariffa aqueous extract. Pharm Biol. 2003;41:325-9.
10. Dhawan K, Kumar S, Sharma A. Antianxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol. 2001;78:165-70.
11. Grundmanna O, Nakajima J, Seo S, Butterweck V. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol. 2007;110:406-11.
12. de Sousa DP, de Almeida RN. Neuroleptic-like properties of the
chloroform extract of Maytenus obtusifolia MART roots. Biol Pharm
Bull. 2005;28:224-5.
13. González-Esquinca AR. Contribución al estudio del género Annona
(Annonaceae), análisis fitoquímico de tres especies del Estado de Chiapas. México: Universidad Nacional Autónoma de México. 2001.
14. Rodgers RJ. Animal models of “anxiety”: Where next? Behavioural
Pharmacology. 1997;8:477-96.
15. Clement Y, Joubert Ch, Kopp C, Lepicard E, Venault P, Misslin R, et al. A principal component analysis study. Neural Plasticity. 2007;2007:1-8.
16. Archer J. Tests for emotionality in rats and mice: A review. Animal Behav. 1973;21:205-35.
17. Silvania MM, Macedo DS, Melo CT, Monteiro AP, Rodríguez AC. Central activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu in mice. J Pharm Pharmacol. 2004;56:389-93.
18. Lipkind D, Sakov A, Kafkafi N, Elmer GI, Benjamini Y, Golani I. New
replicable anxiety-related measures of wall vs. center behavior of mice in the open field. J Appl Physiol. 2004; 97:347-59.
19. Pérez M, Lara D, Jacobsen KX, Vázquez-García M, Crespo-Ramírez M,
Flores-Gracia C, et al. Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat
models of anxiety. Eur J Neurosci. 2006;23:2749-59.
20. Pérez M, Hernández-Gómez AM, Arizmendi-García Y, Jacobsen KX, Lara D, Flores-Gracia C, et al. Role of the amygdaloid cholecystokinin (CCK)/ gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK- 8S on anxiety-like behavior and [3H]GABA release. Eur J Neurosci. 2007;26:3614-30.
21. Pérez M, Gallegos-Cari A, Arizmendi-García Y, Marcellino D, Fuxe K. Role of the dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis. Prog Neurobiol. 2010; 90:198-216.
22. Dawson GR, Tricklebank MD. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci. 1995;16;33-6.
23. Treit D, Menard J, Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav. 1993; 44:463-9.
24. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14:149-67.
25. Lister RG. The use of a plus-maze to measure anxiety in the mouse.
Psychopharmacology. 1987;92:180-5.
26. Grundmann O, Nakajima JI, Seo S, Butterweck V. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. J Ethnopharmacol. 2006;110:406-11.
27. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980;13:167-70.
28. Costall B, Jones BJ, Kelly ME, Taylor RJ, Tomkins DM. Exploration of mice in a black and white test box: Validation as a model of anxiety. Pharmacology Biochemistry & Behavior. 1988; 32:777-85.
29. Bill DJ, Coleman J, Hallett I, Middlefell VC, Rhodes KF, Fletcher A. The
enantiomers of zacopride: an intraspecies comparison of their potencies
in functional and anxiolytic models. Br J Pharmacol. 1995;115(5):775-80.
30. Sluyter F, Kortet M, Bohus B, van Oortmerssen A. Behavioral stress
response of genetically selected aggressive and nonaggressive wild house mice in the shock-probe/defensive burying test. Pharmacol
Biochem Behav. 1996;54:113-6.
31. Treit D. A comparison of anxiolytic and nonanxiolytic agents in the shockprobe/ burying test for anxiolytics. Pharmacol Biochem Behav. 1989; 36:203-5.
32. Sluyter F, Korte M, Van Baal GCM, De Ruiter AJH, van Oortmerssen A. Y chromosomal and sex effects on the behavioral stress response in the defensive burying test in wild house mice. Physiology and Behavior. 1999; 67:579-85.
33. De Boer SF, Koolhaas JM. Defensive burying in rodents: Ethology,
neurobiology and psychopharmacology. Eur J Pharmacol. 2003;463:145-61.
34. Ichimaru Y, Egawa T, Sawa A. 5-HT1Areceptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol. 1995; 68:65-70.
35. Njung’e K, Handley SL. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav. 1991;38:63-7.
36. Borsini F, Podhorna J, Marazziti D. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology.
2002;163:121-41.
37. Matsushita M, Egashira N, Harada S, Okuno R, Mishima K, Iwasaki K, et al. Perospirone, a novel antipsychotic drug, inhibits marble-burying behavior via 5-HT1A receptor in mice: Implications for obsessive-compulsive disorder. J Pharmacol Sci. 2005; 99:154-9.
38. Ariza SY, Rincón J, Guerrero MF. Efectos sobre el sistema nervioso central del extracto etanólico y fracciones de Hygrophila tyttha Leonard. Rev Col Cienc Quím Farm. 2006;35:106-19.
39. Saitoh A, Hirose N, Yamada M, Yamada M, Nozaki Ch, Oka T, et al.
Changes in emotional behavior of mice in the hole-board test after olfactory bulbectomy. J Pharmacol Sci. 2006; 102:377-86.
40. Lourenço da Silva A, Elisabetsky E. Interference of propylene glycol with the hole-board test. Brazilian Journal of Medical and Biological Research. 2001;34:545-7.
41. Ohl F, Holsboer F, Landgraf R. The modified hole board as a differential screen for behavior in rodents. Behav Res Meth Instrum Comput. 2001;33:392-7.
42. Kameia J, Matsunawaa Y, Miyataa S, Tanakab S, Saitoha A. Effects of
nociceptin on the exploratory behavior of mice in the hole-board test. Eur J Pharmacol. 2004;489:77-87.
43. Takeda H, Tsuji M, Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic andror anxiolytic state in mice. Eur J Pharmacol. 1998;350:21-9.
44. Sonavane G, Sarveiya V, Kasture V, Kasture SB. Behavioural actions of Myristica fragrans seeds. Indian J Pharmacol. 2001;33:417-24.
45. Tsuji M, Takeda H, Matsumiya T. Different effects of 5-HT1A receptor
agonists and benzodiazepine anxiolytics on the emotional state of naive and stressed mice: A study using the holeboard test. Psychopharmacology. 2000; 152:157-66.
46. Jung JW, Ahna NY, Oha HR, Lee BK, Lee KJ, Kimb SY, et al. Anxiolytic
effects of the aqueous extract of Uncaria rhynchophylla. J Ethnopharmacol. 2006;108:193-7.
47. Kim WK, Jung JW, Ahn NY, Oh HR, Lee BK, Oh JK, et al. 2004. Anxiolyticlike effects of extracts from Albizzia julibrissin bark in the elevated plusmaze in rats. Life Sciences. 2004; 75:2787-95.
48. Huanga F, Xiong Y, Xub L, Maa S, Doua Ch. Sedative and hypnotic
activities of the ethanol fraction from Fructus schisandrae in mice and rats. J Ethnopharmacol. 2007;110:471-5.
49. Ayoka AO, Akomolafe RO, Iwalewa EO, Akanmub MA, Ukponmwan OE. Sedative, antiepileptic and antipsychotic effects of Spondias bombin L. (Anacardiaceae) in mice and rats. J Ethnopharmacol. 2006;103:166-75.
50. Both FL, Meneghini L, Kerber VA, Henriques AT, Elisabetsky E. Psychopharmacological profile of the alkaloid psychollatine as a 5HT2A/C serotonin modulator. J Nat Prod. 2005;68:374-80.
Cómo citar
Rejón-Orantes, J. del C., Placer Perdomo, D., & Roldán, G. (2010). Pruebas no condicionadas en ratones para evaluar la actividad ansiolítica de sustancias extraídas de plantas. Universitas Medica, 52(1), 78–89. https://doi.org/10.11144/Javeriana.umed52-1.pcrp
Sección
Artículos de revisión